Grupo de investigación del servicio de cardiología del Hospital Universitario 12 de Octubre.
Investigador principal del grupo: Dr. Fernando Arribas Ynsaurriaga

Members:
Dr. Rafael Salguero Bodes
Dr. Adolfo Fontenla Cerezuela
Dr. Julián Palomino Doza
Dra. M. Elena Montañez Delmás

Back to top
Learn more

This Foundation manages the activity of the Institute for Health Research (IdISSC, http://www.idissc.org/) of the Clínico San Carlos University Hospital. The IdISSC is the structure that coordinates the R+D+i activity of the Hospital Clinico San Carlos with other entities such as the research groups of the Schools of Medicine, Pharmacy, Biological Sciences, Chemistry, Physics and Industrial Engineering of the Complutense University and the Polytechnic University of Madrid, the Pedro Laín Entralgo Agency and other entities belonging to the Madrid Health Service (SERMAS) as those of primary care providers in the area of influence of HCSC and some units of the Carlos III Hospital. Cardiovascular diseases is one of the five main areas of reserach of this Institution.

The Foundation aims to promote scientific and technological research as well as training and teaching in health sciences, to improve the quality of care at the Getafe University Hospital. Its main specific objectives are the promotion and coordination of the development of scientific research programs applied to Biomedicine and Health Sciences as well as to facilitate research and training of researchers in collaboration with the Alfonso X El Sabio University, the Madrid Health Service (SERMAS), and with other public and private institutions. The activities of the Foundation are structured around three areas of basic and clinical research: 1) Fragility, aging and disability. 2 ) Inflammatory , infectious and chronic diseases. 3 ) Tumor pathology and systems. Within the area of chronic diseases, atrial fibrillation has been recognized as one of the main research activities for the Foundation.

The FIBHGM is the Hospital's instrument for the promotion, management and development of research. The funds come from research grants, agreements, donations, clinical trials and royalties from your patents and registrations. As a non-profit organization, it dedicates all its income - including those of indirect expenses (overheads) - to finance the research support activities, to increase its infrastructures and to the operation of the FIBHGM itself. The Institute seeks to achieve excellent research and knowledge transfer, through a process of continuous improvement of the various aspects related to it. To this end, the activities of the Institute are geared towards meeting the needs of the people who comprise it, applying up-to-date scientific knowledge, using equitably and efficiently the available resources and with the commitment, participation, satisfaction and development of all the workers of the Institute.

The Foundation manages the activity of the Institute for Health Research of the Hospiatl La Paz (IdiPAZ, www.idipaz.es). IdiPAZ was formally established on 15 December 2009) and coordinates the activity of several research groups from La Paz University Hospital (HULP), the Autonomous University of Madrid, the Madrid Health Service and the Pedro Lain Entralgo Agency for Training, Research and Health Studies in the Community of Madrid. One of the main areas of interest of IdiPAZ is Cardiovascular Research .
The mission of IdiPAZ is to establish itself as a leader in translational biomedical research on a national and international level. To achieve this, the Institute aims to promote high quality, basic, clinical, epidemiological and health services research. IdiPAZ manages all of the resources for research, development and innovation at the centre in order to contribute to the promotion and protection of the health of the population and facilitates access to official calls for public funding, both general and specific, for Health Research Institutes.

The main objective of the Foundation for Biomedical Research of Puerta de Hierro University Hospital is to contribute researchers with a structure, support and resources needed to improve the quality of their results promoting economic development that would allow to increase scientific productivity with full transparency and a translational approach: from bench to bedside. The Foundation manages the scientific and technical activities of the Institute for Health Research of the University Hopsital Puerta de Hierro (IDIPHIM). The Institute englobes the following entities: the Research Foundation of the Hospital, the Madrid Health Service (SERMAS), the Autonomous University of Madrid, and the Pedro Laín Entralgo Agency for Training, Research and Health Studies in the Region of Madrid.

The Foundation for Biomedical Research of Ramón y Cajal University Hospital was created to manage scientific and technical research and to enhance the areas of teaching in the field of health sciences at the Ramón y Cajal University Hospital. The Foundation manages the Institute for Health Research of Ramón y Cajal University Hospital (IRYCIS, http://www.irycis.org/composicion_fibio.htm) which integrates and coordinates several research groups from the Ramón y Cajal University Hospital, three Universities of Madrid (Complutense, Autonomous and Alcalá de Henares, the Madrid Health Service (SERMAS), the Carlos III Health Institute and the Pedro Lain Entralgo Agency for Training, Research and Health Studies in the Region of Madrid. The Institute was created as a multidisciplinary and translational biomedical research structure oriented to the basic, clinical, epidemiological, and health research services research encompassing assistance, research, and teaching both at national and international levels.

Research Lines:
The Department of Pharmacology included several research groups working on cardiovascular pharmacology:

• Cardiac pharmacology: Electrophysiological mechanisms involved in the genesis of cardiac arrhythmias, Endogenous and pharmacological regulation of cardiac ionic channels, Genetic basis of arrhythmia and drug-induced arrhythmia.
• Vascular pharmacology. Signaling pathways involved in the generation and damage of target organs caused by systemic and pulmonar hypertension. Endogenous and pharmacological regulation of ionic channels in smooth muscle cells.
• Pre-clinical evaluation of new cardiovascular drugs.